Environmental risk assessment of medicinal products for human use - Scientific guideline
Second European Medicines Agency and COCIR bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, 7 October 2024
Dear EFIM Members,
We are pleased to announce that the Swedish Society of Internal Medicine will be hosting the13th Winter School of the European School of Internal Medicine, in February from 9th– 15th 2025 in Björkliden, Sweden.
It will be the final edition for the Swedish Society hosting the winter School in Björkliden, Sweden, and as every year it will offer very active educational programme, bringing together residents from across Europe to advance knowledge, share best practices, and foster connections.
Human medicines European public assessment report (EPAR): Dzuveo, sufentanil, Date of authorisation: 25/06/2018, Revision: 8, Status: Authorised
European Medicines Agency’s data protection notice for the Referentials Management System (RMS) activities
Human medicines European public assessment report (EPAR): VeraSeal, human fibrinogen,human thrombin, Date of authorisation: 10/11/2017, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Resolor, prucalopride, Date of authorisation: 14/10/2009, Revision: 30, Status: Authorised
Sixth European Medicines Agency - EuropaBio bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, from 1 October 2024, 10:00 (CEST) to 1 October 2024, 12:00 (CEST)
PRIME eligibility requests: 2025 deadlines for submission and timetable for assessment
Human medicines European public assessment report (EPAR): Xarelto, rivaroxaban, Date of authorisation: 30/09/2008, Revision: 42, Status: Authorised